IL-21 receptor is required for the systemic accumulation of activated B and T lymphocytes in MRL/MpJ-Fas lpr/lpr/J mice

Journal of Immunology

Volumn 188, Issue 4, 2012, Pages 1656-1667

  Rankin, Andrew L ^a   Guay, Heath ^a,c   Herber, Deborah ^a   Bertino, Sarah A ^b   Duzanski, Tatyana A ^a   Carrier, Yijun ^a   Keegan, Sean ^a   Senices, Mayra ^a   Stedman, Nancy ^a   Ryan, Mark ^a   Bloom, Laird ^a   Medley, Quintus ^a   Collins, Mary ^a   Nickerson Nutter, Cheryl ^a   Craft, Joe ^b   Young, Deborah ^a   Dunussi Joannopoulos, Kyri ^a  

^a PFIZER INC   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CENTOCOR INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CD4 ANTIGEN; GAMMA INTERFERON; HERMES ANTIGEN; INTERLEUKIN 21 RECEPTOR; L SELECTIN;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CONTROLLED STUDY; GENETIC TRAIT; GERM LINE; GLOMERULUS BASEMENT MEMBRANE; HELPER CELL; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; LYMPHADENOPATHY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTIC INFILTRATION; MONONUCLEAR CELL; MOUSE; NEPHRITIS; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; PROTEINURIA; SKIN DISEASE; SPLENOMEGALY; T EXTRAFOLLICULAR HELPER CELL; T LYMPHOCYTE;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNITY; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; INTERFERON-GAMMA; INTERLEUKINS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHATIC DISEASES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED MRL LPR; MICE, KNOCKOUT; RECEPTORS, INTERLEUKIN-21; SKIN; SPLENOMEGALY; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84856880967     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003871     Document Type: Article

References (81)

1. Cohen, P. L., and R. A. Eisenberg. 1991. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9: 243-269.
2. Andrews, B. S., R. A. Eisenberg, A. N. Theofilopoulos, S. Izui, C. B. Wilson, P. J. McConahey, E. D. Murphy, J. B. Roths, and F. J. Dixon. 1978. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J. Exp. Med. 148: 1198-1215.
3. Shlomchik, M. J., M. P. Madaio, D. Ni, M. Trounstein, and D. Huszar. 1994. The role of B cells in lpr/lpr-induced autoimmunity. J. Exp. Med. 180: 1295-1306. (Pubitemid 24289603)
4. Jevnikar, A. M., M. J. Grusby, and L. H. Glimcher. 1994. Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice. J. Exp. Med. 179: 1137-1143.
5. Jabs, D. A., C. L. Burek, Q. Hu, R. C. Kuppers, B. Lee, and R. A. Prendergast. 1992. Anti-CD4 monoclonal antibody therapy suppresses autoimmune disease in MRL/Mp-lpr/lpr mice. Cell. Immunol. 141: 496-507.
6. Koh, D. R., A. Ho, A. Rahemtulla, W. P. Fung-Leung, H. Griesser, and T. W. Mak. 1995. Murine lupus in MRL/lpr mice lacking CD4 or CD8 T cells. Eur. J. Immunol. 25: 2558-2562.
7. Chan, O. T., L. G. Hannum, A. M. Haberman, M. P. Madaio, and M. J. Shlomchik. 1999. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J. Exp. Med. 189: 1639-1648.
8. Deng, G. M., L. Liu, V. C. Kyttaris, and G. C. Tsokos. 2010. Lupus serum IgG induces skin inflammation through the TNFR1 signaling pathway. J. Immunol. 184: 7154-7161.
9. William, J., C. Euler, S. Christensen, and M. J. Shlomchik. 2002. Evolution of autoantibody responses via somatic hypermutation outside of germinal centers. Science 297: 2066-2070.
10. Odegard, J. M., B. R. Marks, L. D. DiPlacido, A. C. Poholek, D. H. Kono, C. Dong, R. A. Flavell, and J. Craft. 2008. ICOS-dependent extrafollicular helper T cells elicit IgG production via IL-21 in systemic autoimmunity. J. Exp. Med. 205: 2873-2886.
11. Odegard, J. M., L. D. DiPlacido, L. Greenwald, M. Kashgarian, D. H. Kono, C. Dong, R. A. Flavell, and J. Craft. 2009. ICOS controls effector function but not trafficking receptor expression of kidney-infiltrating effector T cells in murine lupus. J. Immunol. 182: 4076-4084.
12. Tada, Y., S. Koarada, Y. Tomiyoshi, F. Morito, M. Mitamura, Y. Haruta, A. Ohta, and K. Nagasawa. 2006. Role of inducible costimulator in the development of lupus in MRL/lpr mice. Clin. Immunol. 120: 179-188. (Pubitemid 44080674)
13. Budd, R. C., J. H. Schumacher, G. Winslow, and T. R. Mosmann. 1991. Elevated production of interferon-gamma and interleukin 4 by mature T cells from autoimmune lpr mice correlates with Pgp-1 (CD44) expression. Eur. J. Immunol. 21: 1081-1084.
14. Schwarting, A., T. Wada, K. Kinoshita, G. Tesch, and V. R. Kelley. 1998. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice. J. Immunol. 161: 494-503. (Pubitemid 28285560)
15. Haas, C., B. Ryffel, and M. Le Hir. 1997. IFN-gamma is essential for the development of autoimmune glomerulonephritis in MRL/Ipr mice. J. Immunol. 158: 5484-5491. (Pubitemid 127681257)
16. Balomenos, D., R. Rumold, and A. N. Theofilopoulos. 1998. Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice. J. Clin. Invest. 101: 364-371. (Pubitemid 28067333)
17. Ozaki, K., K. Kikly, D. Michalovich, P. R. Young, and W. J. Leonard. 2000. Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain. Proc. Natl. Acad. Sci. USA 97: 11439-11444.
18. Spolski, R., and W. J. Leonard. 2008. Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu. Rev. Immunol. 26: 57-79. (Pubitemid 351600371)
19. Asao, H., C. Okuyama, S. Kumaki, N. Ishii, S. Tsuchiya, D. Foster, and K. Sugamura. 2001. Cutting edge: the common gamma-chain is an indispensable subunit of the IL-21 receptor complex. J. Immunol. 167: 1-5. (Pubitemid 32567752)
20. Jin, H., R. Carrio, A. Yu, and T. R. Malek. 2004. Distinct activation signals determine whether IL-21 induces B cell costimulation, growth arrest, or Bim-dependent apoptosis. J. Immunol. 173: 657-665. (Pubitemid 38797396)
21. Brandt, K., S. Bulfone-Paus, D. C. Foster, and R. Rückert. 2003. Interleukin-21 inhibits dendritic cell activation and maturation. Blood 102: 4090-4098. (Pubitemid 37486993)
22. Pelletier, M., A. Bouchard, and D. Girard. 2004. In vivo and in vitro roles of IL-21 in inflammation. J. Immunol. 173: 7521-7530. (Pubitemid 39628193)
23. Parrish-Novak, J., S. R. Dillon, A. Nelson, A. Hammond, C. Sprecher, J. A. Gross, J. Johnston, K. Madden, W. Xu, J. West, et al. 2000. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408: 57-63.
24. Ozaki, K., R. Spolski, C. G. Feng, C. F. Qi, J. Cheng, A. Sher, H. C. Morse, III, C. Liu, P. L. Schwartzberg, and W. J. Leonard. 2002. A critical role for IL-21 in regulating immunoglobulin production. Science 298: 1630-1634. (Pubitemid 35387203)
25. Zotos, D., J. M. Coquet, Y. Zhang, A. Light, K. D'Costa, A. Kallies, L. M. Corcoran, D. I. Godfrey, K. M. Toellner, M. J. Smyth, et al. 2010. IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism. J. Exp. Med. 207: 365-378.
26. Ozaki, K., R. Spolski, R. Ettinger, H. P. Kim, G. Wang, C. F. Qi, P. Hwu, D. J. Shaffer, S. Akilesh, D. C. Roopenian, et al. 2004. Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J. Immunol. 173: 5361-5371. (Pubitemid 39392119)
27. Ettinger, R., G. P. Sims, A. M. Fairhurst, R. Robbins, Y. S. da Silva, R. Spolski, W. J. Leonard, and P. E. Lipsky. 2005. IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells. J. Immunol. 175: 7867-7879. (Pubitemid 41798347)
28. Linterman, M. A., L. Beaton, D. Yu, R. R. Ramiscal, M. Srivastava, J. J. Hogan, N. K. Verma, M. J. Smyth, R. J. Rigby, and C. G. Vinuesa. 2010. IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses. J. Exp. Med. 207: 353-363.
29. Bessa, J., M. Kopf, and M. F. Bachmann. 2010. Cutting edge: IL-21 and TLR signaling regulate germinal center responses in a B cell-intrinsic manner. J. Immunol. 184: 4615-4619.
30. Poholek, A. C., K. Hansen, S. G. Hernandez, D. Eto, A. Chandele, J. S. Weinstein, X. Dong, J. M. Odegard, S. M. Kaech, A. L. Dent, et al. 2010. In vivo regulation of Bcl6 and T follicular helper cell development. J. Immunol. 185: 313-326.
31. Chtanova, T., S. G. Tangye, R. Newton, N. Frank, M. R. Hodge, M. S. Rolph, and C. R. Mackay. 2004. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. J. Immunol. 173: 68-78. (Pubitemid 38797327)
32. Nurieva, R., X. O. Yang, G. Martinez, Y. Zhang, A. D. Panopoulos, L. Ma, K. Schluns, Q. Tian, S. S. Watowich, A. M. Jetten, and C. Dong. 2007. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448: 480-483. (Pubitemid 47123514)
33. Bryant, V. L., C. S. Ma, D. T. Avery, Y. Li, K. L. Good, L. M. Corcoran, R. de Waal Malefyt, and S. G. Tangye. 2007. Cytokine-mediated regulation of human B cell differentiation into Ig-secreting cells: predominant role of IL-21 produced by CXCR5+ T follicular helper cells. J. Immunol. 179: 8180-8190.
34. Nurieva, R. I., Y. Chung, D. Hwang, X. O. Yang, H. S. Kang, L. Ma, Y. H. Wang, S. S. Watowich, A. M. Jetten, Q. Tian, and C. Dong. 2008. Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity 29: 138-149.
35. Vogelzang, A., H. M. McGuire, D. Yu, J. Sprent, C. R. Mackay, and C. King. 2008. A fundamental role for interleukin-21 in the generation of T follicular helper cells. Immunity 29: 127-137.
36. Pan, H. F., D. Q. Ye, and X. P. Li. 2008. Type 17 T-helper cells might be a promising therapeutic target for systemic lupus erythematosus. Nat. Clin. Pract. Rheumatol. 4: 352-353. (Pubitemid 351974005)
37. Hsu, H. C., P. Yang, J. Wang, Q. Wu, R. Myers, J. Chen, J. Yi, T. Guentert, A. Tousson, A. L. Stanus, et al. 2008. Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat. Immunol. 9: 166-175.
38. Korn, T., E. Bettelli, W. Gao, A. Awasthi, A. Jäger, T. B. Strom, M. Oukka, and V. K. Kuchroo. 2007. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 448: 484-487. (Pubitemid 47123515)
39. Sawalha, A. H., K. M. Kaufman, J. A. Kelly, A. J. Adler, T. Aberle, J. Kilpatrick, E. K. Wakeland, Q. Z. Li, A. E. Wandstrat, D. R. Karp, et al. 2008. Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosus. Ann. Rheum. Dis. 67: 458-461. (Pubitemid 351498423)
40. Hughes, T., X. Kim-Howard, J. A. Kelly, K. M. Kaufman, C. D. Langefeld, J. Ziegler, E. Sanchez, R. P. Kimberly, J. C. Edberg, R. Ramsey-Goldman, et al BIOLUPUS Network. 2011. Fine-mapping and transethnic genotyping establish IL2/IL21 genetic association with lupus and localize this genetic effect to IL21. Arthritis Rheum. 63: 1689-1697.
41. Webb, R., J. T. Merrill, J. A. Kelly, A. Sestak, K. M. Kaufman, C. D. Langefeld, J. Ziegler, R. P. Kimberly, J. C. Edberg, R. Ramsey-Goldman, et al. 2009. A polymorphism within IL21R confers risk for systemic lupus erythematosus. Arthritis Rheum. 60: 2402-2407.
42. Bubier, J. A., T. J. Sproule, O. Foreman, R. Spolski, D. J. Shaffer, H. C. Morse, III, W. J. Leonard, and D. C. Roopenian. 2009. A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice. Proc. Natl. Acad. Sci. USA 106: 1518-1523.
43. Herber, D., T. P. Brown, S. Liang, D. A. Young, M. Collins, and K. Dunussi-Joannopoulos. 2007. IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progression. J. Immunol. 178: 3822-3830. (Pubitemid 46417651)
44. Kasaian, M. T., M. J. Whitters, L. L. Carter, L. D. Lowe, J. M. Jussif, B. Deng, K. A. Johnson, J. S. Witek, M. Senices, R. F. Konz, et al. 2002. IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity. Immunity 16: 559-569. (Pubitemid 34442580)
45. Vlahakos, D., M. H. Foster, A. A. Ucci, K. J. Barrett, S. K. Datta, and M. P. Madaio. 1992. Murine monoclonal anti-DNA antibodies penetrate cells, bind to nuclei, and induce glomerular proliferation and proteinuria in vivo. J. Am. Soc. Nephrol. 2: 1345-1354.
46. Vlahakos, D. V., M. H. Foster, S. Adams, M. Katz, A. A. Ucci, K. J. Barrett, S. K. Datta, and M. P. Madaio. 1992. Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites. Kidney Int. 41: 1690-1700.
47. Jiang, C., J. Foley, N. Clayton, G. Kissling, M. Jokinen, R. Herbert, and M. Diaz. 2007. Abrogation of lupus nephritis in activation-induced deaminase-deficient MRL/lpr mice. J. Immunol. 178: 7422-7431. (Pubitemid 46847470)
48. Habib, T., A. Nelson, and K. Kaushansky. 2003. IL-21: a novel IL-2-family lymphokine that modulates B, T, and natural killer cell responses. J. Allergy Clin. Immunol. 112: 1033-1045.
49. Merino, R., L. Fossati, M. Iwamoto, S. Takahashi, R. Lemoine, N. Ibnou-Zekri, L. Pugliatti, J. Merino, and S. Izui. 1995. Effect of long-term anti-CD4 or anti-CD8 treatment on the development of lpr CD42 CD82 double negative T cells and of the autoimmune syndrome in MRL-lpr/lpr mice. J. Autoimmun. 8: 33-45.
50. Mehal, W. Z., and I. N. Crispe. 1998. TCR ligation on CD8+ T cells creates double-negative cells in vivo. J. Immunol. 161: 1686-1693. (Pubitemid 28387585)
51. Fröhlich, A., J. Kisielow, I. Schmitz, S. Freigang, A. T. Shamshiev, J. Weber, B. J. Marsland, A. Oxenius, and M. Kopf. 2009. IL-21R on T cells is critical for sustained functionality and control of chronic viral infection. Science 324: 1576-1580.
52. Elsaesser, H., K. Sauer, and D. G. Brooks. 2009. IL-21 is required to control chronic viral infection. Science 324: 1569-1572.
53. Yi, J. S., M. Du, and A. J. Zajac. 2009. A vital role for interleukin-21 in the control of a chronic viral infection. Science 324: 1572-1576.
54. Luzina, I. G., S. P. Atamas, C. E. Storrer, L. C. daSilva, G. Kelsoe, J. C. Papadimitriou, and B. S. Handwerger. 2001. Spontaneous formation of germinal centers in autoimmune mice. J. Leukoc. Biol. 70: 578-584. (Pubitemid 32954768)
55. Oliver, A. M., F. Martin, and J. F. Kearney. 1997. Mouse CD38 is down-regulated on germinal center B cells and mature plasma cells. J. Immunol. 158: 1108-1115. (Pubitemid 127469931)
56. Peng, S. L., J. Moslehi, and J. Craft. 1997. Roles of interferon-gamma and interleukin-4 in murine lupus. J. Clin. Invest. 99: 1936-1946. (Pubitemid 27175941)
57. Steinmetz, O. M., J. E. Turner, H. J. Paust, M. Lindner, A. Peters, K. Heiss, J. Velden, H. Hopfer, S. Fehr, T. Krieger, et al. 2009. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis. J. Immunol. 183: 4693-4704.
58. Johnston, R. J., A. C. Poholek, D. DiToro, I. Yusuf, D. Eto, B. Barnett, A. L. Dent, J. Craft, and S. Crotty. 2009. Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science 325: 1006-1010.
59. Barber, D. F., A. Bartolomé, C. Hernandez, J. M. Flores, C. Redondo, C. Fernandez-Arias, M. Camps, T. Rückle, M. K. Schwarz, S. Rodríguez, et al. 2005. PI3Kgamma inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus. Nat. Med. 11: 933-935. (Pubitemid 41294437)
60. Slack, J. H., L. Hang, J. Barkley, R. J. Fulton, L. D'Hoostelaere, A. Robinson, and F. J. Dixon. 1984. Isotypes of spontaneous and mitogen-induced autoantibodies in SLE-prone mice. J. Immunol. 132: 1271-1275. (Pubitemid 14154549)
61. Okamura, M., Y. Kanayama, K. Amastu, N. Negoro, S. Kohda, T. Takeda, and T. Inoue. 1993. Significance of enzyme linked immunosorbent assay (ELISA) for antibodies to double stranded and single stranded DNA in patients with lupus nephritis: correlation with severity of renal histology. Ann. Rheum. Dis. 52: 14-20. (Pubitemid 23018288)
62. Kita, Y., T. Sumida, K. Ichikawa, T. Maeda, F. Yonaha, I. Iwamoto, S. Yoshida, and T. Koike. 1993. V gene analysis of anticardiolipin antibodies from MRL-lpr/lpr mice. J. Immunol. 151: 849-856. (Pubitemid 23215750)
63. Shlomchik, M., M. Mascelli, H. Shan, M. Z. Radic, D. Pisetsky, A. Marshak-Rothstein, and M. Weigert. 1990. Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J. Exp. Med. 171: 265-292.
64. Shlomchik, M. J., A. Marshak-Rothstein, C. B. Wolfowicz, T. L. Rothstein, and M. G. Weigert. 1987. The role of clonal selection and somatic mutation in autoimmunity. Nature 328: 805-811. (Pubitemid 17118532)
65. William, J., C. Euler, and M. J. Shlomchik. 2005. Short-lived plasmablasts dominate the early spontaneous rheumatoid factor response: differentiation pathways, hypermutating cell types, and affinity maturation outside the germinal center. J. Immunol. 174: 6879-6887. (Pubitemid 40705652)
66. Linterman, M. A., R. J. Rigby, R. K. Wong, D. Yu, R. Brink, J. L. Cannons, P. L. Schwartzberg, M. C. Cook, G. D. Walters, and C. G. Vinuesa. 2009. Follicular helper T cells are required for systemic autoimmunity. J. Exp. Med. 206: 561-576.
67. King, C., A. Ilic, K. Koelsch, and N. Sarvetnick. 2004. Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 117: 265-277. (Pubitemid 38496245)
68. Suto, A., A. L. Wurster, S. L. Reiner, and M. J. Grusby. 2006. IL-21 inhibits IFN-gamma production in developing Th1 cells through the repression of Eomesodermin expression. J. Immunol. 177: 3721-3727. (Pubitemid 44359904)
69. Fina, D., M. Sarra, R. Caruso, G. Del Vecchio Blanco, F. Pallone, T. T. MacDonald, and G. Monteleone. 2008. Interleukin 21 contributes to the mucosal T helper cell type 1 response in coeliac disease. Gut 57: 887-892.
70. Hooks, J. J., H. M. Moutsopoulos, S. A. Geis, N. I. Stahl, J. L. Decker, and A. L. Notkins. 1979. Immune interferon in the circulation of patients with autoimmune disease. N. Engl. J. Med. 301: 5-8. (Pubitemid 9226519)
71. al-Janadi, M., S. al-Balla, A. al-Dalaan, and S. Raziuddin. 1993. Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases. J. Clin. Immunol. 13: 58-67. (Pubitemid 23047997)
72. Prud'homme, G. J., D. H. Kono, and A. N. Theofilopoulos. 1995. Quantitative polymerase chain reaction analysis reveals marked overexpression of interleukin-1 beta, interleukin-1 and interferon-gamma mRNA in the lymph nodes of lupus-prone mice. Mol. Immunol. 32: 495-503.
73. Takahashi, S., L. Fossati, M. Iwamoto, R. Merino, R. Motta, T. Kobayakawa, and S. Izui. 1996. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice. J. Clin. Invest. 97: 1597-1604. (Pubitemid 26105469)
74. Wong, C. K., L. C. Lit, L. S. Tam, E. K. Li, P. T. Wong, and C. W. Lam. 2008. Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. Clin. Immunol. 127: 385-393.
75. Doreau, A., A. Belot, J. Bastid, B. Riche, M. C. Trescol-Biemont, B. Ranchin, N. Fabien, P. Cochat, C. Pouteil-Noble, P. Trolliet, et al. 2009. Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat. Immunol. 10: 778-785.
76. Chen, X. Q., Y. C. Yu, H. H. Deng, J. Z. Sun, Z. Dai, Y. W. Wu, and M. Yang. 2010. Plasma IL-17A is increased in new-onset SLE patients and associated with disease activity. J. Clin. Immunol. 30: 221-225.
77. Crispïn, J. C., M. Oukka, G. Bayliss, R. A. Cohen, C. A. Van Beek, I. E. Stillman, V. C. Kyttaris, Y. T. Juang, and G. C. Tsokos. 2008. Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J. Immunol. 181: 8761-8766.
78. Biswas, P. S., S. Gupta, E. Chang, L. Song, R. A. Stirzaker, J. K. Liao, G. Bhagat, and A. B. Pernis. 2010. Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice. J. Clin. Invest. 120: 3280-3295.
79. Kyttaris, V. C., Z. Zhang, V. K. Kuchroo, M. Oukka, and G. C. Tsokos. 2010. Cutting edge: IL-23 receptor deficiency prevents the development of lupus nephritis in C57BL/6-lpr/lpr mice. J. Immunol. 184: 4605-4609.
80. Tieng, A. T., and E. Peeva. 2008. B-cell-directed therapies in systemic lupus erythematosus. Semin. Arthritis Rheum. 38: 218-227.
81. Hoffman, R. W. 2004. T cells in the pathogenesis of systemic lupus erythematosus. Clin. Immunol. 113: 4-13. (Pubitemid 39468261)